Past Euretina RMCR Awards
Since the awards programme was established in 2018, we have received a high number of high-quality submissions, and progressed with new awards every year. We are proud to share the winners of past research awards below.
Any queries should be directed to [email protected]
2025 Winners
Josef Huemer, United Kingdom: €254,158.01
Deep phenotyping of Optical Coherence Tomography biomarkers of cardiovascular disease using deep learning and genome wide analysis
Kanmin Xue, United Kingdom : €297,257
Assessing Physiological Risk Factors for Retinopathy of Prematurity (ROP) Progression and Effects of Anti-VEGF Therapy on Neurodevelopment: PROGRESS-ROP Study
2024 Winners
Maximillian Pfau, Switzerland: €282,129
Enhanced vision and imaging test for enabling treatment trials in early and intermediate AMD
Javier Zarranz-Ventura, Spain: €227,503
Prediction of treatment needs using a hybrid Artificial Intelligence-based Management Assistant (ALMA) tool in Neovascular Age-related Macular Degeneration
2023 Winners
Pearse A. Keane, United Kingdom: €120,994
Predicting Progressive Macular Atrophy in Patients Undergoing Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration Using Multi-Modal Imaging, Genetics, and Artificial Intelligence
João Pedro Marques, Portugal: €299,879
“EYS on” Gene Editing for Retinitis Pigmentosa 25
Enrico Borrelli, Italy: €263,806
The Role of Mitochondria in Geographic Atrophy Progression in Age-Related Macular Degeneration
2022 Winners
Suzanne Yzer, The Netherlands: €186,091
Risk of Posterior Staphyloma in Highly Myopic Europeans: From Epidemiology to Anatomy and Back
Claudia Farinha, Portugal: €294,704
Diet, Lifestyle, Systemic Medication and Genetics: Can the Risk for AMD be Modulated? (AMD_LifeGene)
2021 Winners
Robert P. Finger, Germany: €293,350
Microbiome, Metabolome and Complement Activation in Age-Related Macular Degeneration at the University Hospital Bonn
Dominik Fischer, UK: €287,359
REGENT (RETiNal GENE ThERapy immuNE REsponNsE) at Oxford University Hospitals NHS Foundation Trust
2020 Winners
Rufino Martins da Silva, Portugal: €223,981,59
Metabolomics: An Integrative Tool for Investigating the Pathogenesis of Age-Related Macular Degeneration at AIBILI – Association for Innovation and Biomedical Research on Light and Image
Gian Marco Tosi, Italy: €190,752.50
The C-Type Lectin Receptor CD93 as a New Target in Retinal Vascular Diseases at the University of Siena
2019 Winners
Camiel Boon, The Netherlands: €201,233
Juvenile X-Linked Retinoschisis: Assessing the Clinical and Genetic Spectrum in Preparation for Therapy
Roy Schwartz, UK: €262,112
Deep Learning, Large Datasets, Genome-Wide Analysis and Histological Correlates to Determine the Role of Reticular Pseudodrusen in the Progression of Age-Related Macular Degeneration

